Clinical Outcomes of Treatment by Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery in Patients With Chronic Kidney Disease Undergoing Index Revascularization in Ontario
Author(s) -
William Chan,
Joan Ivanov,
Dennis T. Ko,
Stephen E. Fremes,
Vivek Rao,
Sanjit S. Jolly,
Warren J. Cantor,
Shahar Lavi,
Christopher B. Overgaard,
Marc Ruel,
Jack V. Tu,
Vladimír Džavík
Publication year - 2015
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.114.001973
Subject(s) - medicine , percutaneous coronary intervention , hazard ratio , cardiology , kidney disease , revascularization , coronary artery disease , renal function , stent , surgery , coronary artery bypass surgery , confidence interval , myocardial infarction , artery
There is a paucity of data on the comparative effectiveness of percutaneous coronary intervention using contemporary drug-eluting stent (DES) compared with coronary artery bypass graft (CABG) surgery in patients with chronic kidney disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom